"Obamacare" may mean less innovation, R&D: Keckley (5:28)
Healthcare economist Paul Keckley says the upholding of President Obama's healthcare reform bill might mean biotech companies will be less likely to invest in research and development.
Hard-edged reporting, insight and analysis, Reuters TV breaks ground creating informative news and financial videos. Showcasing Reuters’ 3000 award-winning journalists, Reuters TV delivers high-energy investigative journalism with concise explanations. Check it out and let us know what you think.